The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports


San Diego Biopharma Features 'Strong and Balanced Pipeline'

Research Report
  ()
An H.C. Wainwright & Co. report discussed what sets this company's asset apart from similar products. read more >
News Update

Dosing Begins for California Biopharma's Proof-of-Concept Trial in Plaque Psoriasis

News Update
  ()
This U.S. study follows encouraging results from a Phase 1b trial in the same indication in Australia. read more >
News Update

Biotech Stresses Need to Target Only Toxic Oligomer in Alzheimer's Therapies

News Update
  ()
The company cites the recent discontinuation of other firms' clinical programs as proof. read more >

Now Cashed Up, Biopharma to Advance Cholesterol-Lowering Therapy

Research Report
  ()
A ROTH Capital Partners report reviewed this New Jersey firm's plans for its lead asset. read more >

Several Data Catalysts Expected in 2019 for 'Underappreciated Story'

Research Report
  ()
An H.C. Wainwright & Co. report discussed what those are and why they could impact the biotech's valuation. read more >

Rare Diseases Biotech Provides Opportunity

Research Report
  ()
A ROTH Capital Partners report discussed why the stock price is at its current level and noted upcoming catalysts for the company. read more >
News Update

Tech Firm to Offer Solution to Inefficient, Expensive Health Clinic Business Model

News Update
  ()
The company will roll out virtual, remote medical services to change how primary care practices are run. read more >

Biopharma Expected to Bring 'Two First-in-Class Antibiotics to Market in 2019'

Research Report
  ()
The likely timelines for approval and commercialization of each drug are discussed in an H.C. Wainwright report. read more >
News Update

Antibody Therapeutics Developer to Present at March Alzheimer's/Parkinson's Conference

News Update
  ()
The biotech was selected to discuss its antibodies that selectively target toxic forms of alpha-synuclein. read more >

Health Tech Firm Completes Enrollment for Female Sexual Function Trial

Research Report
  ()
A Ladenburg Thalmann report reviewed the study design and purpose. read more >

Analyst: Biotech to Have 'Eventful Year' with Data Readouts in Three Indications

Research Report
  ()
This California company expects results from clinical trials in liver disease and psoriasis in 2019. read more >

Large US Market Now Open to Livestock Feed Antibiotic Replacement

  ()
Proprietary OxC-beta livestock feed supplement can supplant the need for maintenance antibiotics. read more >

Coverage Initiated on Cancer Vaccine Firm

Research Report
  ()
An H.C. Wainwright & Co. report explained the reasons for its "bullish view" on this California-based life sciences company. read more >

Coverage Initiated on Producer of Hemp-Derived Cannabidiol Products

Research Report
  ()
A ROTH Capital Partners report presented the reasons for investing in this company. read more >

U.S. Biotech Makes 'The Acquisition We Were Waiting For'

Research Report
  ()
By tucking in this retinal gene therapy firm, the Massachusetts-based company gains assets and synergy. read more >

After Financing Close, Biotech's Subsidiary to Operate Independently

Research Report
  ()
An H.C. Wainwright & Co. report explained the purpose of the funding and how any resulting developments would positively impact the former parent company. read more >

Biotech to Launch Preclinical Studies of Antibody in Eight Cancer Types

Research Report
  ()
This company's new trials, preferred dosing and upcoming biologics license application submission are discussed in an H.C. Wainwright & Co. report. read more >

FDA Grants Breakthrough Status to Biopharma's Lead Candidate for Liver Disease

Research Report
  ()
The California firm's most advanced asset is advancing through Phase 2b, according to a ROTH Capital Partners report. read more >

Biopharma's Foundation Provides for Downside Protection, Upside Realization

Research Report
  ()
An H.C. Wainwright & Co. report described this Israeli firm's solid revenue picture and addressed the undervaluation of a key therapeutic candidate. read more >
News Update

Biotech Identifies Antibody Drug Candidates to Target Toxic Protein Implicated in Parkinson's Disease

News Update
  ()
The Canadian company continues seeking partners to leverage its discovery and development platform. read more >

Clinical Movement Expected in 2019 on Pharma Firm's 'Gene Therapy Promise'

Research Report
  ()
A number of data readouts are expected in the coming months, which could derisk and accelerate development programs, according to an H.C. Wainwright & Co. report. read more >

Report Highlights Biopharma's Breakthroughs on Treatment of Life-Threatening Pediatric Liver Diseases

Research Report
  ()
Analyst expects "transformational year" for company with a phase 3 trial underway. read more >

Biopharma's Drug Well Tolerated in Opioid Withdrawal Study

Research Report
  ()
An H.C. Wainwright & Co. discussed these proof-of-concept data and described the company's planned Phase 1 study. read more >

Accelerated Approval Could Be 'Game Changer' for Biotech

Research Report
  ()
This Canadian company's immunotherapeutic targeting ovarian cancer could advance to market sooner, according to a Mackie Research Capital Corp. note. read more >
News Update

Biotech Offers Reason for Others' Failed Trials of Potential Alzheimer's Disease Treatments

News Update
  ()
This Canadian developer of therapeutics for neurodegenerative diseases bases its opinion, in part, on its own preclinical findings. read more >
Showing Results: 26 to 50 of 72 Prev Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe